Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 14 04:00PM ET
4.64
Dollar change
+0.55
Percentage change
13.45
%
Index- P/E- EPS (ttm)-3.20 Insider Own2.64% Shs Outstand14.02M Perf Week-9.55%
Market Cap65.28M Forward P/E- EPS next Y- Insider Trans0.81% Shs Float13.70M Perf Month-24.18%
Income-16.61M PEG- EPS next Q- Inst Own6.46% Short Float2.42% Perf Quarter39.34%
Sales7.11M P/S9.18 EPS this Y- Inst Trans32.58% Short Ratio1.43 Perf Half Y100.00%
Book/sh0.26 P/B17.68 EPS next Y- ROA-34.10% Short Interest0.33M Perf Year82.68%
Cash/sh0.62 P/C7.53 EPS next 5Y- ROE-70.25% 52W Range1.29 - 7.75 Perf YTD-0.22%
Dividend Est.- P/FCF19.66 EPS past 5Y23.21% ROI-52.89% 52W High-40.13% Beta2.07
Dividend TTM- Quick Ratio0.75 Sales past 5Y-21.33% Gross Margin-4.78% 52W Low259.69% ATR (14)0.60
Dividend Ex-DateApr 01, 2022 Current Ratio0.75 EPS Y/Y TTM27.61% Oper. Margin-109.23% RSI (14)41.25 Volatility13.47% 10.75%
Employees5 Debt/Eq0.47 Sales Y/Y TTM-36.30% Profit Margin-233.56% Recom- Target Price-
Option/ShortYes / Yes LT Debt/Eq0.30 EPS Q/Q-25.88% Payout- Rel Volume0.71 Prev Close4.09
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume231.49K Price4.64
SMA20-19.37% SMA50-19.25% SMA20043.66% Trades Volume163,395 Change13.45%
Feb-26-25 02:00PM
Feb-20-25 08:30AM
Feb-18-25 08:30AM
Feb-13-25 03:00PM
Feb-03-25 07:30AM
03:51PM Loading…
Jan-31-25 03:51PM
Jan-15-25 07:00AM
Jan-10-25 08:30AM
Jan-09-25 11:30AM
Dec-18-24 04:00PM
Nov-27-24 07:00AM
Nov-12-24 05:23PM
Nov-06-24 08:30AM
Oct-30-24 10:30AM
Oct-23-24 05:00PM
08:30AM Loading…
Oct-09-24 08:30AM
Oct-02-24 08:30AM
Sep-10-24 11:00AM
Sep-09-24 08:00AM
Aug-26-24 08:45AM
Aug-23-24 11:00AM
Aug-19-24 06:30PM
Aug-13-24 08:30AM
Jul-25-24 08:30AM
ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Johnson Virland AChief Financial OfficerDec 06 '24Buy3.003,0009,0003,000Dec 10 02:54 PM
Tassiopoulos PeterChief Executive OfficerSep 09 '24Buy2.065,00010,278420,000Sep 11 11:57 AM